Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lymphangioleiomyomatosis | 64 | 2024 | 206 | 14.240 |
Why?
|
Tuberous Sclerosis | 79 | 2024 | 1039 | 10.710 |
Why?
|
Tumor Suppressor Proteins | 79 | 2022 | 2795 | 5.450 |
Why?
|
Angiomyolipoma | 33 | 2024 | 189 | 4.340 |
Why?
|
Sirolimus | 29 | 2024 | 1541 | 3.900 |
Why?
|
Birt-Hogg-Dube Syndrome | 10 | 2024 | 40 | 3.620 |
Why?
|
Kidney Neoplasms | 45 | 2024 | 4278 | 3.590 |
Why?
|
TOR Serine-Threonine Kinases | 43 | 2024 | 2057 | 3.510 |
Why?
|
Monomeric GTP-Binding Proteins | 11 | 2022 | 197 | 3.270 |
Why?
|
Carcinoma, Renal Cell | 26 | 2024 | 3183 | 2.870 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 5 | 2024 | 323 | 2.570 |
Why?
|
Pneumothorax | 9 | 2020 | 392 | 1.920 |
Why?
|
Autophagy | 15 | 2021 | 1350 | 1.770 |
Why?
|
Multiprotein Complexes | 14 | 2024 | 1107 | 1.770 |
Why?
|
Neuropeptides | 9 | 2011 | 952 | 1.360 |
Why?
|
Lung Neoplasms | 25 | 2023 | 13446 | 1.290 |
Why?
|
Repressor Proteins | 25 | 2005 | 2969 | 1.250 |
Why?
|
Proto-Oncogene Proteins | 12 | 2021 | 4520 | 1.150 |
Why?
|
Lung Diseases | 9 | 2023 | 1939 | 1.100 |
Why?
|
Protein Kinases | 9 | 2009 | 1611 | 1.090 |
Why?
|
Cysts | 5 | 2021 | 684 | 1.060 |
Why?
|
Genes, Tumor Suppressor | 12 | 2006 | 1060 | 1.020 |
Why?
|
Glutathione | 4 | 2022 | 588 | 1.010 |
Why?
|
Antibiotics, Antineoplastic | 7 | 2021 | 678 | 0.990 |
Why?
|
Lysosomes | 3 | 2021 | 932 | 0.910 |
Why?
|
Vascular Endothelial Growth Factor D | 6 | 2019 | 61 | 0.900 |
Why?
|
Neoplastic Syndromes, Hereditary | 2 | 2023 | 249 | 0.870 |
Why?
|
Amino Acid Transport System y+ | 1 | 2022 | 41 | 0.800 |
Why?
|
Signal Transduction | 34 | 2024 | 23597 | 0.800 |
Why?
|
Pinocytosis | 2 | 2021 | 64 | 0.800 |
Why?
|
Schizosaccharomyces pombe Proteins | 4 | 2013 | 177 | 0.790 |
Why?
|
Cystine | 1 | 2022 | 96 | 0.780 |
Why?
|
gamma-Glutamyltransferase | 2 | 2022 | 141 | 0.780 |
Why?
|
Proteins | 20 | 2012 | 5994 | 0.770 |
Why?
|
Loss of Heterozygosity | 11 | 2016 | 663 | 0.740 |
Why?
|
Estrogens | 5 | 2016 | 1528 | 0.690 |
Why?
|
Neoplastic Stem Cells | 2 | 2022 | 1351 | 0.680 |
Why?
|
Tumor Escape | 1 | 2023 | 371 | 0.680 |
Why?
|
Schizosaccharomyces | 4 | 2013 | 236 | 0.670 |
Why?
|
Cell Transformation, Neoplastic | 11 | 2017 | 2838 | 0.660 |
Why?
|
Lung | 16 | 2023 | 10046 | 0.660 |
Why?
|
Kidney Diseases, Cystic | 2 | 2018 | 182 | 0.650 |
Why?
|
Polycystic Kidney Diseases | 3 | 2016 | 133 | 0.630 |
Why?
|
Class III Phosphatidylinositol 3-Kinases | 1 | 2018 | 17 | 0.630 |
Why?
|
Animals | 80 | 2024 | 168735 | 0.620 |
Why?
|
Polyamines | 1 | 2019 | 132 | 0.620 |
Why?
|
Receptors, Retinoic Acid | 1 | 2019 | 229 | 0.620 |
Why?
|
Mice | 53 | 2024 | 81782 | 0.610 |
Why?
|
Hydroxychloroquine | 3 | 2018 | 429 | 0.610 |
Why?
|
Thoracostomy | 1 | 2018 | 78 | 0.570 |
Why?
|
Chromosomes, Human, Pair 9 | 11 | 1998 | 533 | 0.560 |
Why?
|
MicroRNAs | 4 | 2019 | 3788 | 0.560 |
Why?
|
Humans | 179 | 2024 | 765926 | 0.540 |
Why?
|
Mice, SCID | 12 | 2021 | 2626 | 0.540 |
Why?
|
Pentose Phosphate Pathway | 2 | 2014 | 125 | 0.540 |
Why?
|
Cell Proliferation | 21 | 2024 | 10426 | 0.520 |
Why?
|
Chromosomes, Human, Pair 16 | 6 | 2002 | 340 | 0.510 |
Why?
|
Multiple Pulmonary Nodules | 1 | 2018 | 173 | 0.510 |
Why?
|
Intracellular Signaling Peptides and Proteins | 6 | 2017 | 2879 | 0.490 |
Why?
|
Lysophosphatidylcholines | 1 | 2015 | 77 | 0.490 |
Why?
|
Respiratory System Agents | 1 | 2015 | 30 | 0.480 |
Why?
|
Benzophenanthridines | 1 | 2014 | 26 | 0.480 |
Why?
|
Proto-Oncogene Proteins c-raf | 2 | 2006 | 205 | 0.470 |
Why?
|
Receptors, LDL | 1 | 2017 | 492 | 0.460 |
Why?
|
Cell Line | 17 | 2021 | 15540 | 0.460 |
Why?
|
Tumor Microenvironment | 4 | 2022 | 3940 | 0.460 |
Why?
|
6-Aminonicotinamide | 1 | 2013 | 8 | 0.450 |
Why?
|
Fibroblasts | 4 | 2021 | 4161 | 0.450 |
Why?
|
Embryo, Mammalian | 2 | 2019 | 1674 | 0.450 |
Why?
|
Polycystic Kidney, Autosomal Dominant | 3 | 2008 | 166 | 0.440 |
Why?
|
Ribosomal Protein S6 | 4 | 2007 | 70 | 0.440 |
Why?
|
TRPP Cation Channels | 4 | 2021 | 177 | 0.430 |
Why?
|
Mutation | 35 | 2021 | 30192 | 0.430 |
Why?
|
Estradiol | 6 | 2014 | 1947 | 0.430 |
Why?
|
Sequence Analysis, RNA | 3 | 2021 | 2036 | 0.430 |
Why?
|
Enzyme Inhibitors | 5 | 2020 | 3716 | 0.420 |
Why?
|
Plakophilins | 1 | 2012 | 32 | 0.410 |
Why?
|
Immunotherapy | 2 | 2019 | 4746 | 0.410 |
Why?
|
Oligopeptides | 1 | 2018 | 1193 | 0.410 |
Why?
|
Myocytes, Smooth Muscle | 2 | 2017 | 701 | 0.400 |
Why?
|
Adherens Junctions | 1 | 2012 | 90 | 0.400 |
Why?
|
RNA-Binding Proteins | 1 | 2021 | 1882 | 0.390 |
Why?
|
Neoplasm Proteins | 5 | 2020 | 3592 | 0.390 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2014 | 715 | 0.390 |
Why?
|
Proto-Oncogene Proteins B-raf | 5 | 2014 | 2053 | 0.380 |
Why?
|
Membrane Glycoproteins | 2 | 2024 | 3690 | 0.370 |
Why?
|
Mice, Knockout | 13 | 2024 | 14450 | 0.370 |
Why?
|
Cell Cycle Proteins | 5 | 2014 | 3431 | 0.360 |
Why?
|
HeLa Cells | 4 | 2021 | 3070 | 0.360 |
Why?
|
Arginine | 2 | 2005 | 931 | 0.360 |
Why?
|
Phosphorylation | 14 | 2021 | 8279 | 0.360 |
Why?
|
Lipid Metabolism | 2 | 2018 | 1893 | 0.360 |
Why?
|
Cell Line, Tumor | 19 | 2024 | 17060 | 0.350 |
Why?
|
Immunoblotting | 7 | 2018 | 1643 | 0.350 |
Why?
|
Gene Expression Regulation | 6 | 2021 | 11895 | 0.340 |
Why?
|
Chromosomes, Human, Pair 13 | 2 | 2003 | 191 | 0.340 |
Why?
|
Ribosomal Protein S6 Kinases, 70-kDa | 5 | 2013 | 101 | 0.340 |
Why?
|
Sense Organs | 1 | 2009 | 21 | 0.340 |
Why?
|
Phosphatidylinositol 3-Kinases | 4 | 2023 | 2877 | 0.340 |
Why?
|
Immunosuppressive Agents | 4 | 2018 | 4213 | 0.330 |
Why?
|
Neoplasms, Multiple Primary | 4 | 2019 | 589 | 0.330 |
Why?
|
Kidney | 14 | 2021 | 7073 | 0.320 |
Why?
|
Ligases | 2 | 2002 | 330 | 0.320 |
Why?
|
Tumor Cells, Cultured | 7 | 2019 | 6101 | 0.320 |
Why?
|
Homeostasis | 3 | 2017 | 3338 | 0.320 |
Why?
|
Up-Regulation | 5 | 2021 | 4130 | 0.320 |
Why?
|
Gene Expression Profiling | 8 | 2019 | 9525 | 0.310 |
Why?
|
Lymphangiogenesis | 1 | 2010 | 171 | 0.310 |
Why?
|
DNA Mutational Analysis | 8 | 2014 | 4111 | 0.300 |
Why?
|
Mice, Inbred NOD | 4 | 2021 | 1837 | 0.300 |
Why?
|
Adaptor Proteins, Signal Transducing | 4 | 2014 | 2897 | 0.300 |
Why?
|
Chromosome Deletion | 4 | 2014 | 1384 | 0.300 |
Why?
|
HEK293 Cells | 4 | 2021 | 4257 | 0.300 |
Why?
|
Cholesterol | 1 | 2017 | 2902 | 0.300 |
Why?
|
Cell Movement | 7 | 2019 | 5190 | 0.290 |
Why?
|
Drosophila Proteins | 2 | 2009 | 1704 | 0.290 |
Why?
|
T-Lymphocytes | 2 | 2023 | 10256 | 0.290 |
Why?
|
Heat-Shock Proteins | 1 | 2011 | 790 | 0.280 |
Why?
|
Cilia | 2 | 2008 | 499 | 0.280 |
Why?
|
Apoptosis | 8 | 2023 | 9505 | 0.280 |
Why?
|
Mice, Nude | 7 | 2022 | 3608 | 0.280 |
Why?
|
Drug Discovery | 1 | 2015 | 1062 | 0.280 |
Why?
|
Cell Survival | 5 | 2014 | 5745 | 0.270 |
Why?
|
rho GTP-Binding Proteins | 2 | 2012 | 280 | 0.270 |
Why?
|
Carrier Proteins | 4 | 2017 | 4909 | 0.270 |
Why?
|
Mitochondria | 2 | 2017 | 3669 | 0.260 |
Why?
|
Female | 68 | 2024 | 396141 | 0.260 |
Why?
|
Neoplasms | 8 | 2022 | 22340 | 0.260 |
Why?
|
Gene Expression Regulation, Fungal | 2 | 2013 | 496 | 0.250 |
Why?
|
Carcinoma | 2 | 2009 | 2311 | 0.250 |
Why?
|
Receptor, Notch1 | 2 | 2019 | 516 | 0.250 |
Why?
|
Glucose | 3 | 2014 | 4335 | 0.240 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2014 | 1167 | 0.240 |
Why?
|
G1 Phase | 2 | 2005 | 403 | 0.240 |
Why?
|
Receptors, Notch | 1 | 2009 | 751 | 0.240 |
Why?
|
Tissue Banks | 1 | 2006 | 183 | 0.240 |
Why?
|
Interphase | 2 | 2003 | 226 | 0.240 |
Why?
|
Genetic Predisposition to Disease | 7 | 2020 | 18074 | 0.230 |
Why?
|
Disease Models, Animal | 14 | 2021 | 18292 | 0.230 |
Why?
|
Oxidative Stress | 4 | 2023 | 3140 | 0.230 |
Why?
|
Centrosome | 1 | 2005 | 209 | 0.230 |
Why?
|
Cell Differentiation | 5 | 2017 | 11639 | 0.230 |
Why?
|
Transcription Factors | 7 | 2023 | 12129 | 0.230 |
Why?
|
von Hippel-Lindau Disease | 3 | 2004 | 154 | 0.230 |
Why?
|
RNA, Small Interfering | 5 | 2022 | 3419 | 0.230 |
Why?
|
Receptors, Progesterone | 2 | 2000 | 1152 | 0.230 |
Why?
|
Leucine | 1 | 2005 | 546 | 0.220 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2006 | 409 | 0.220 |
Why?
|
Proto-Oncogene Proteins c-akt | 5 | 2023 | 2455 | 0.220 |
Why?
|
Anoikis | 2 | 2016 | 49 | 0.210 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 4 | 2017 | 303 | 0.210 |
Why?
|
Ubiquitin-Protein Ligases | 3 | 2004 | 1894 | 0.210 |
Why?
|
Cell Adhesion | 3 | 2015 | 3089 | 0.210 |
Why?
|
Vital Capacity | 2 | 2017 | 995 | 0.210 |
Why?
|
Cyclins | 1 | 2005 | 598 | 0.210 |
Why?
|
Molecular Targeted Therapy | 4 | 2022 | 2823 | 0.210 |
Why?
|
Glutathione Disulfide | 1 | 2022 | 32 | 0.200 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 3 | 2013 | 478 | 0.200 |
Why?
|
MAP Kinase Signaling System | 3 | 2013 | 1489 | 0.200 |
Why?
|
Cysteine Proteases | 1 | 2022 | 13 | 0.200 |
Why?
|
Gene Expression Regulation, Neoplastic | 8 | 2020 | 8603 | 0.200 |
Why?
|
Serine | 2 | 2021 | 825 | 0.190 |
Why?
|
Canavanine | 3 | 2007 | 14 | 0.190 |
Why?
|
Genes, Regulator | 1 | 2023 | 373 | 0.190 |
Why?
|
Clinical Trials as Topic | 3 | 2015 | 8037 | 0.190 |
Why?
|
Biological Transport | 2 | 2022 | 2081 | 0.190 |
Why?
|
Phosphopyruvate Hydratase | 1 | 2021 | 127 | 0.190 |
Why?
|
Ritanserin | 1 | 2021 | 10 | 0.190 |
Why?
|
Tamoxifen | 2 | 2003 | 964 | 0.190 |
Why?
|
Down-Regulation | 4 | 2021 | 2925 | 0.190 |
Why?
|
Carbonic Anhydrase II | 1 | 2021 | 21 | 0.190 |
Why?
|
Fungal Proteins | 1 | 2005 | 900 | 0.180 |
Why?
|
Epithelial-Mesenchymal Transition | 4 | 2019 | 750 | 0.180 |
Why?
|
Diacylglycerol Kinase | 1 | 2021 | 47 | 0.180 |
Why?
|
Xenograft Model Antitumor Assays | 6 | 2019 | 3604 | 0.180 |
Why?
|
Interleukin-6 | 2 | 2021 | 3225 | 0.180 |
Why?
|
Phosphoserine | 1 | 2021 | 203 | 0.180 |
Why?
|
Biological Assay | 2 | 2016 | 626 | 0.180 |
Why?
|
RNA, Messenger | 5 | 2022 | 12768 | 0.180 |
Why?
|
Inhibitor of Differentiation Protein 2 | 1 | 2020 | 30 | 0.180 |
Why?
|
Cysteine-Rich Protein 61 | 1 | 2020 | 39 | 0.180 |
Why?
|
Chromosome Mapping | 12 | 2003 | 4617 | 0.180 |
Why?
|
Transaminases | 1 | 2021 | 199 | 0.180 |
Why?
|
Mice, Inbred C57BL | 7 | 2022 | 22327 | 0.180 |
Why?
|
Immunohistochemistry | 11 | 2019 | 11030 | 0.180 |
Why?
|
Pulmonary Surfactants | 1 | 2021 | 169 | 0.180 |
Why?
|
Adenocarcinoma, Clear Cell | 1 | 2002 | 217 | 0.170 |
Why?
|
IMP Dehydrogenase | 1 | 2020 | 34 | 0.170 |
Why?
|
Rats | 10 | 2021 | 23708 | 0.170 |
Why?
|
Neoplasm Metastasis | 6 | 2012 | 4882 | 0.170 |
Why?
|
Ribosomal Protein S6 Kinases | 3 | 2006 | 203 | 0.170 |
Why?
|
Protein Kinase Inhibitors | 5 | 2019 | 5691 | 0.170 |
Why?
|
Ventilator-Induced Lung Injury | 1 | 2021 | 135 | 0.170 |
Why?
|
Ribonucleosides | 1 | 2020 | 79 | 0.170 |
Why?
|
Wnt2 Protein | 1 | 2019 | 29 | 0.170 |
Why?
|
COUP Transcription Factor II | 1 | 2019 | 19 | 0.160 |
Why?
|
Research Design | 2 | 2015 | 6204 | 0.160 |
Why?
|
Nodal Protein | 1 | 2019 | 36 | 0.160 |
Why?
|
Microtubule-Associated Proteins | 3 | 2013 | 1065 | 0.160 |
Why?
|
Molecular Sequence Data | 12 | 2014 | 17596 | 0.160 |
Why?
|
Immunoenzyme Techniques | 5 | 2006 | 1695 | 0.160 |
Why?
|
Base Sequence | 12 | 2019 | 12405 | 0.160 |
Why?
|
Organoids | 2 | 2022 | 740 | 0.160 |
Why?
|
Apoptosis Regulatory Proteins | 3 | 2013 | 1150 | 0.150 |
Why?
|
Amiloride | 1 | 2018 | 116 | 0.150 |
Why?
|
Endostatins | 1 | 2019 | 167 | 0.150 |
Why?
|
Cell Nucleus | 3 | 2021 | 2864 | 0.150 |
Why?
|
Neurobiology | 1 | 1999 | 135 | 0.150 |
Why?
|
Acetyl-CoA Carboxylase | 1 | 2018 | 72 | 0.150 |
Why?
|
Microphthalmia-Associated Transcription Factor | 1 | 2020 | 257 | 0.150 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2019 | 2945 | 0.150 |
Why?
|
Cells, Cultured | 6 | 2019 | 18962 | 0.150 |
Why?
|
Cytoplasm | 2 | 2003 | 1498 | 0.150 |
Why?
|
Transfection | 6 | 2014 | 5738 | 0.150 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2020 | 318 | 0.150 |
Why?
|
GTPase-Activating Proteins | 1 | 2001 | 465 | 0.150 |
Why?
|
Vascular Endothelial Growth Factor Receptor-3 | 1 | 2018 | 118 | 0.150 |
Why?
|
Mycophenolic Acid | 1 | 2020 | 348 | 0.150 |
Why?
|
Microsatellite Repeats | 4 | 2006 | 784 | 0.150 |
Why?
|
Reactive Oxygen Species | 3 | 2014 | 2141 | 0.150 |
Why?
|
Vitamin D-Binding Protein | 1 | 2018 | 129 | 0.140 |
Why?
|
Lung Diseases, Fungal | 1 | 2018 | 123 | 0.140 |
Why?
|
Genetic Linkage | 4 | 2006 | 2342 | 0.140 |
Why?
|
Alleles | 5 | 2007 | 6891 | 0.140 |
Why?
|
Calcium-Binding Proteins | 2 | 2017 | 1077 | 0.140 |
Why?
|
Chloroquine | 2 | 2021 | 276 | 0.140 |
Why?
|
Genes, p53 | 2 | 2011 | 711 | 0.140 |
Why?
|
Forkhead Transcription Factors | 2 | 2023 | 1623 | 0.140 |
Why?
|
Pulmonary Alveoli | 1 | 2020 | 665 | 0.140 |
Why?
|
Interferons | 1 | 2021 | 714 | 0.140 |
Why?
|
Amino Acid Sequence | 8 | 2013 | 13398 | 0.140 |
Why?
|
Adenocarcinoma | 3 | 2006 | 6360 | 0.140 |
Why?
|
Phosphoproteins | 3 | 2014 | 2444 | 0.140 |
Why?
|
Polymorphism, Genetic | 5 | 2007 | 4249 | 0.130 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2019 | 385 | 0.130 |
Why?
|
Dextrans | 1 | 2018 | 570 | 0.130 |
Why?
|
Naphthyridines | 2 | 2015 | 182 | 0.130 |
Why?
|
Exons | 6 | 2002 | 2393 | 0.130 |
Why?
|
Urinary Bladder Neoplasms | 2 | 2019 | 2176 | 0.130 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2012 | 3637 | 0.130 |
Why?
|
Endothelium, Lymphatic | 1 | 2016 | 63 | 0.130 |
Why?
|
RNA Interference | 4 | 2017 | 2829 | 0.130 |
Why?
|
Antineoplastic Agents | 4 | 2015 | 13631 | 0.130 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2019 | 335 | 0.130 |
Why?
|
Mosaicism | 1 | 2019 | 481 | 0.130 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2019 | 659 | 0.130 |
Why?
|
Polymorphism, Single-Stranded Conformational | 4 | 2006 | 325 | 0.130 |
Why?
|
Genetic Markers | 8 | 2014 | 2603 | 0.130 |
Why?
|
Mucositis | 1 | 2017 | 107 | 0.130 |
Why?
|
Phenotype | 9 | 2024 | 16714 | 0.130 |
Why?
|
Germ-Line Mutation | 5 | 2020 | 1885 | 0.130 |
Why?
|
Sterol Regulatory Element Binding Proteins | 1 | 2015 | 25 | 0.130 |
Why?
|
Mutation, Missense | 2 | 2004 | 2589 | 0.120 |
Why?
|
Shock | 1 | 2018 | 316 | 0.120 |
Why?
|
Male | 33 | 2024 | 363815 | 0.120 |
Why?
|
Protein Transport | 1 | 2021 | 1938 | 0.120 |
Why?
|
Models, Biological | 7 | 2015 | 9443 | 0.120 |
Why?
|
Wnt Proteins | 1 | 2019 | 722 | 0.120 |
Why?
|
Lymphocytes | 1 | 2023 | 2601 | 0.120 |
Why?
|
Phospholipases A2 | 1 | 2015 | 197 | 0.120 |
Why?
|
Biopsy | 5 | 2016 | 6766 | 0.120 |
Why?
|
Renal Insufficiency | 1 | 2021 | 810 | 0.120 |
Why?
|
Nucleotides | 1 | 2017 | 453 | 0.120 |
Why?
|
Pneumonia, Bacterial | 1 | 2018 | 319 | 0.120 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2003 | 1535 | 0.120 |
Why?
|
Biomedical Research | 3 | 2016 | 3458 | 0.120 |
Why?
|
Tomography, X-Ray Computed | 6 | 2024 | 20690 | 0.120 |
Why?
|
Fibrinogen | 1 | 2018 | 895 | 0.120 |
Why?
|
Aging | 1 | 2014 | 8725 | 0.120 |
Why?
|
Protein Binding | 4 | 2012 | 9296 | 0.120 |
Why?
|
Sequence Homology, Amino Acid | 4 | 2007 | 2743 | 0.120 |
Why?
|
Respiratory Function Tests | 3 | 2020 | 1692 | 0.120 |
Why?
|
Receptors, Estrogen | 2 | 2000 | 2242 | 0.110 |
Why?
|
Amino Acids | 2 | 2013 | 1709 | 0.110 |
Why?
|
Age of Onset | 1 | 2021 | 3343 | 0.110 |
Why?
|
Cell Death | 2 | 2022 | 1676 | 0.110 |
Why?
|
Epithelium | 2 | 2015 | 1603 | 0.110 |
Why?
|
Mice, Transgenic | 4 | 2021 | 9541 | 0.110 |
Why?
|
Oncogenes | 2 | 2023 | 1232 | 0.110 |
Why?
|
Mice, Inbred BALB C | 2 | 2022 | 6209 | 0.110 |
Why?
|
Cell Shape | 1 | 2015 | 372 | 0.110 |
Why?
|
Cell Division | 4 | 2006 | 4466 | 0.110 |
Why?
|
Hemangiopericytoma | 1 | 2014 | 71 | 0.110 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2021 | 3801 | 0.110 |
Why?
|
Cough | 1 | 2018 | 598 | 0.110 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 2 | 2006 | 473 | 0.110 |
Why?
|
Mice, Inbred A | 1 | 2013 | 244 | 0.110 |
Why?
|
Opportunistic Infections | 1 | 2017 | 376 | 0.110 |
Why?
|
Lysosomal-Associated Membrane Protein 2 | 1 | 2013 | 53 | 0.110 |
Why?
|
Respiratory Insufficiency | 1 | 2022 | 1241 | 0.110 |
Why?
|
DNA, Neoplasm | 3 | 2006 | 1739 | 0.110 |
Why?
|
Membrane Proteins | 3 | 2011 | 7847 | 0.110 |
Why?
|
Dimerization | 2 | 2006 | 880 | 0.110 |
Why?
|
Dogs | 2 | 2012 | 3824 | 0.110 |
Why?
|
Kidney Diseases | 1 | 2004 | 2100 | 0.110 |
Why?
|
Adult | 27 | 2024 | 223088 | 0.110 |
Why?
|
Teratogens | 1 | 2013 | 120 | 0.110 |
Why?
|
Lung Transplantation | 1 | 2002 | 1311 | 0.100 |
Why?
|
gamma Catenin | 1 | 2012 | 45 | 0.100 |
Why?
|
Keratin-14 | 1 | 2012 | 57 | 0.100 |
Why?
|
Adenosine Triphosphate | 1 | 2019 | 2001 | 0.100 |
Why?
|
Desmosomes | 1 | 2012 | 72 | 0.100 |
Why?
|
Caspase 1 | 1 | 2013 | 227 | 0.100 |
Why?
|
Catenins | 1 | 2012 | 44 | 0.100 |
Why?
|
Blotting, Western | 5 | 2016 | 5019 | 0.100 |
Why?
|
Fluorescent Antibody Technique | 1 | 2017 | 2470 | 0.100 |
Why?
|
Prostaglandins | 1 | 2014 | 396 | 0.100 |
Why?
|
Maximum Tolerated Dose | 1 | 2015 | 895 | 0.100 |
Why?
|
Heme Oxygenase-1 | 1 | 2014 | 364 | 0.100 |
Why?
|
Protein Biosynthesis | 1 | 1999 | 2089 | 0.100 |
Why?
|
Cardiomegaly | 1 | 2014 | 590 | 0.100 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2009 | 1239 | 0.100 |
Why?
|
Forced Expiratory Volume | 1 | 2017 | 1828 | 0.100 |
Why?
|
Pericytes | 1 | 2014 | 299 | 0.090 |
Why?
|
Immunoprecipitation | 2 | 2021 | 871 | 0.090 |
Why?
|
Radiography, Thoracic | 1 | 2018 | 1319 | 0.090 |
Why?
|
Bronchi | 1 | 2015 | 843 | 0.090 |
Why?
|
Drug Therapy, Combination | 2 | 2018 | 6306 | 0.090 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2021 | 4563 | 0.090 |
Why?
|
GTP Phosphohydrolases | 2 | 2005 | 523 | 0.090 |
Why?
|
Stress, Physiological | 1 | 2018 | 1404 | 0.090 |
Why?
|
Immunity, Innate | 1 | 2023 | 3078 | 0.090 |
Why?
|
Predictive Value of Tests | 4 | 2015 | 15401 | 0.090 |
Why?
|
Mass Spectrometry | 2 | 2015 | 2194 | 0.090 |
Why?
|
Chest Pain | 1 | 2018 | 1102 | 0.090 |
Why?
|
Exosomes | 1 | 2015 | 417 | 0.090 |
Why?
|
Precipitin Tests | 2 | 2004 | 812 | 0.090 |
Why?
|
Transcription, Genetic | 3 | 2021 | 7599 | 0.090 |
Why?
|
Oncogene Proteins | 1 | 1995 | 710 | 0.090 |
Why?
|
Drug Delivery Systems | 1 | 2022 | 2206 | 0.090 |
Why?
|
Pluripotent Stem Cells | 1 | 2017 | 808 | 0.090 |
Why?
|
Nephrology | 1 | 2014 | 270 | 0.090 |
Why?
|
Skin Neoplasms | 2 | 2007 | 5836 | 0.090 |
Why?
|
Heterozygote | 5 | 2017 | 2796 | 0.090 |
Why?
|
Forecasting | 1 | 2019 | 2936 | 0.090 |
Why?
|
Sirtuins | 1 | 2013 | 323 | 0.090 |
Why?
|
Protein Processing, Post-Translational | 2 | 2009 | 1961 | 0.090 |
Why?
|
Integrases | 1 | 2012 | 520 | 0.090 |
Why?
|
Risk Assessment | 6 | 2021 | 24275 | 0.090 |
Why?
|
Glutamine | 1 | 2013 | 574 | 0.090 |
Why?
|
Diarrhea | 1 | 2017 | 1315 | 0.080 |
Why?
|
Dyspnea | 1 | 2018 | 1351 | 0.080 |
Why?
|
Leukocytes, Mononuclear | 1 | 2017 | 1852 | 0.080 |
Why?
|
Respiration, Artificial | 1 | 2021 | 2726 | 0.080 |
Why?
|
Genes, Dominant | 2 | 2004 | 855 | 0.080 |
Why?
|
Epidermis | 1 | 2012 | 535 | 0.080 |
Why?
|
Amino Acid Transport Systems | 2 | 2013 | 34 | 0.080 |
Why?
|
Confidence Intervals | 1 | 2015 | 2915 | 0.080 |
Why?
|
Endothelial Cells | 1 | 2022 | 3586 | 0.080 |
Why?
|
Glioblastoma | 2 | 2009 | 3458 | 0.080 |
Why?
|
Flow Cytometry | 4 | 2021 | 5880 | 0.080 |
Why?
|
Respiratory Tract Infections | 1 | 2017 | 1008 | 0.080 |
Why?
|
Genetic Testing | 3 | 2021 | 3594 | 0.080 |
Why?
|
Genotype | 5 | 2019 | 13026 | 0.080 |
Why?
|
Brain Neoplasms | 3 | 2002 | 9065 | 0.080 |
Why?
|
Hair | 1 | 2012 | 509 | 0.080 |
Why?
|
Melanoma | 1 | 2007 | 5695 | 0.080 |
Why?
|
Women's Health | 1 | 2018 | 2081 | 0.080 |
Why?
|
Headache | 1 | 2017 | 1261 | 0.080 |
Why?
|
DNA | 5 | 2006 | 7193 | 0.080 |
Why?
|
Prognosis | 5 | 2018 | 29890 | 0.080 |
Why?
|
Muscle, Smooth | 2 | 2004 | 931 | 0.080 |
Why?
|
Protein Structure, Tertiary | 2 | 2006 | 3749 | 0.070 |
Why?
|
Plasmids | 2 | 2004 | 2267 | 0.070 |
Why?
|
Polymerase Chain Reaction | 8 | 2014 | 6058 | 0.070 |
Why?
|
Ethionine | 1 | 2007 | 10 | 0.070 |
Why?
|
Middle Aged | 17 | 2024 | 223016 | 0.070 |
Why?
|
Brain | 6 | 2016 | 27179 | 0.070 |
Why?
|
Genome, Human | 2 | 2018 | 4443 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2016 | 3661 | 0.070 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 4851 | 0.070 |
Why?
|
Mitochondrial Proteins | 1 | 2013 | 975 | 0.070 |
Why?
|
Oxygen Consumption | 1 | 2013 | 1872 | 0.070 |
Why?
|
Young Adult | 6 | 2024 | 59857 | 0.070 |
Why?
|
Ovariectomy | 1 | 2009 | 612 | 0.070 |
Why?
|
Risk Factors | 5 | 2018 | 74850 | 0.070 |
Why?
|
Gene Deletion | 2 | 2005 | 2667 | 0.070 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2009 | 433 | 0.070 |
Why?
|
Antibody Specificity | 2 | 1999 | 1061 | 0.070 |
Why?
|
Microscopy, Fluorescence | 3 | 2012 | 2627 | 0.070 |
Why?
|
Indoles | 1 | 2014 | 1833 | 0.060 |
Why?
|
Gene Knockdown Techniques | 3 | 2017 | 1601 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2014 | 9373 | 0.060 |
Why?
|
Treatment Outcome | 4 | 2017 | 65194 | 0.060 |
Why?
|
Myocytes, Cardiac | 1 | 2014 | 1672 | 0.060 |
Why?
|
Nevus | 1 | 2007 | 204 | 0.060 |
Why?
|
Pedigree | 4 | 2019 | 4535 | 0.060 |
Why?
|
Transcriptional Activation | 1 | 2011 | 1743 | 0.060 |
Why?
|
Testis | 1 | 2009 | 782 | 0.060 |
Why?
|
Extracellular Matrix | 1 | 2013 | 1727 | 0.060 |
Why?
|
Cell Fractionation | 1 | 2005 | 244 | 0.060 |
Why?
|
Haploinsufficiency | 2 | 2017 | 334 | 0.060 |
Why?
|
NF-kappa B | 1 | 2013 | 2492 | 0.060 |
Why?
|
Genes, Lethal | 1 | 2005 | 224 | 0.060 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2017 | 3796 | 0.060 |
Why?
|
Blotting, Northern | 2 | 2004 | 1546 | 0.060 |
Why?
|
Paraffin Embedding | 1 | 2006 | 302 | 0.060 |
Why?
|
Sulfonamides | 1 | 2014 | 1979 | 0.060 |
Why?
|
Monitoring, Physiologic | 1 | 2012 | 1793 | 0.060 |
Why?
|
Guanosine Diphosphate | 1 | 2004 | 79 | 0.060 |
Why?
|
RNA | 2 | 2004 | 2716 | 0.060 |
Why?
|
Angiofibroma | 2 | 2002 | 55 | 0.060 |
Why?
|
Ovary | 1 | 2009 | 961 | 0.060 |
Why?
|
Rare Diseases | 1 | 2010 | 629 | 0.060 |
Why?
|
Protein Prenylation | 1 | 2004 | 69 | 0.060 |
Why?
|
Angiogenesis Inhibitors | 1 | 2014 | 2046 | 0.060 |
Why?
|
DNA, Complementary | 3 | 1997 | 1984 | 0.060 |
Why?
|
Breast Neoplasms | 2 | 2014 | 21069 | 0.060 |
Why?
|
Biological Evolution | 1 | 2009 | 1075 | 0.060 |
Why?
|
Peer Review, Research | 1 | 2007 | 342 | 0.060 |
Why?
|
Hyperplasia | 2 | 2014 | 1142 | 0.060 |
Why?
|
Embryonic Stem Cells | 1 | 2011 | 1242 | 0.050 |
Why?
|
Cyclin B | 1 | 2003 | 104 | 0.050 |
Why?
|
Diagnosis, Differential | 2 | 2018 | 12973 | 0.050 |
Why?
|
Neoplasm Transplantation | 2 | 2020 | 2008 | 0.050 |
Why?
|
G2 Phase | 1 | 2003 | 134 | 0.050 |
Why?
|
Philadelphia Chromosome | 2 | 1994 | 119 | 0.050 |
Why?
|
Benzamides | 1 | 2009 | 1376 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10727 | 0.050 |
Why?
|
Transforming Growth Factor beta | 1 | 2011 | 1996 | 0.050 |
Why?
|
Receptors, Steroid | 1 | 2003 | 155 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2019 | 16039 | 0.050 |
Why?
|
Consensus | 2 | 2024 | 3202 | 0.050 |
Why?
|
CDC2 Protein Kinase | 1 | 2003 | 212 | 0.050 |
Why?
|
Repetitive Sequences, Nucleic Acid | 3 | 1995 | 780 | 0.050 |
Why?
|
Glioma | 1 | 1997 | 3491 | 0.050 |
Why?
|
Glucosephosphate Dehydrogenase | 2 | 2014 | 209 | 0.050 |
Why?
|
Receptors, Angiotensin | 1 | 2022 | 141 | 0.050 |
Why?
|
Skin | 1 | 2016 | 4481 | 0.050 |
Why?
|
Glycogen | 1 | 2003 | 252 | 0.050 |
Why?
|
Drosophila | 1 | 2009 | 1505 | 0.050 |
Why?
|
Glutathione Transferase | 1 | 2004 | 562 | 0.050 |
Why?
|
Glutamic Acid | 2 | 2014 | 1181 | 0.050 |
Why?
|
Mitosis | 1 | 2007 | 1175 | 0.050 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2004 | 335 | 0.050 |
Why?
|
Rats, Nude | 1 | 2021 | 105 | 0.050 |
Why?
|
Chromosomes, Human, Y | 1 | 2002 | 163 | 0.050 |
Why?
|
Engineering | 1 | 2021 | 55 | 0.050 |
Why?
|
Wound Healing | 1 | 2012 | 2794 | 0.050 |
Why?
|
Angiolipoma | 1 | 2021 | 12 | 0.050 |
Why?
|
Phosphatidic Acids | 1 | 2021 | 50 | 0.050 |
Why?
|
Adenosine Triphosphatases | 1 | 2005 | 839 | 0.050 |
Why?
|
Lung Compliance | 1 | 2021 | 207 | 0.050 |
Why?
|
Cytochromes c | 1 | 2021 | 173 | 0.050 |
Why?
|
Sequence Homology | 1 | 2001 | 197 | 0.050 |
Why?
|
Lymphangiomyoma | 1 | 2000 | 9 | 0.050 |
Why?
|
Reproducibility of Results | 2 | 2017 | 20133 | 0.040 |
Why?
|
ras Proteins | 1 | 2006 | 1054 | 0.040 |
Why?
|
Thyroid Neoplasms | 1 | 2014 | 2354 | 0.040 |
Why?
|
Proton-Translocating ATPases | 1 | 2021 | 112 | 0.040 |
Why?
|
Aged | 7 | 2019 | 171163 | 0.040 |
Why?
|
Epilepsy | 1 | 2016 | 3317 | 0.040 |
Why?
|
In Situ Nick-End Labeling | 1 | 2021 | 610 | 0.040 |
Why?
|
Cell Cycle | 2 | 2013 | 2920 | 0.040 |
Why?
|
Microscopy, Confocal | 2 | 2014 | 1966 | 0.040 |
Why?
|
Giant Cells | 1 | 2001 | 187 | 0.040 |
Why?
|
Asthma | 2 | 2018 | 6268 | 0.040 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2003 | 1677 | 0.040 |
Why?
|
Transcription Initiation Site | 1 | 2020 | 189 | 0.040 |
Why?
|
Genomics | 1 | 2016 | 5925 | 0.040 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2007 | 1763 | 0.040 |
Why?
|
Binding Sites | 2 | 2009 | 5999 | 0.040 |
Why?
|
Adolescent | 7 | 2024 | 88811 | 0.040 |
Why?
|
Estrogen Antagonists | 1 | 2000 | 151 | 0.040 |
Why?
|
Survival Analysis | 3 | 2018 | 10086 | 0.040 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2013 | 2307 | 0.040 |
Why?
|
Molecular Weight | 2 | 1998 | 2160 | 0.040 |
Why?
|
Neoplasm Invasiveness | 2 | 2020 | 3599 | 0.040 |
Why?
|
Peptide Hydrolases | 1 | 2022 | 608 | 0.040 |
Why?
|
Phenylenediamines | 1 | 2019 | 89 | 0.040 |
Why?
|
Endocrine Glands | 1 | 1999 | 101 | 0.040 |
Why?
|
Lymph Nodes | 2 | 2002 | 3447 | 0.040 |
Why?
|
Gene Expression | 2 | 2021 | 7581 | 0.040 |
Why?
|
Receptors, GABA | 1 | 2001 | 312 | 0.040 |
Why?
|
Epithelial Cells | 2 | 2015 | 3684 | 0.040 |
Why?
|
Microfilament Proteins | 2 | 1994 | 1130 | 0.040 |
Why?
|
Hybrid Cells | 3 | 1994 | 420 | 0.040 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 1994 | 685 | 0.040 |
Why?
|
Child | 8 | 2014 | 80568 | 0.040 |
Why?
|
Rats, Mutant Strains | 1 | 1997 | 59 | 0.040 |
Why?
|
Liposomes | 1 | 2022 | 786 | 0.040 |
Why?
|
Cosmids | 2 | 1995 | 105 | 0.040 |
Why?
|
Allosteric Regulation | 1 | 2019 | 425 | 0.040 |
Why?
|
Restriction Mapping | 2 | 1995 | 848 | 0.040 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 1998 | 322 | 0.040 |
Why?
|
Gene Knockout Techniques | 1 | 2020 | 798 | 0.040 |
Why?
|
Astrocytoma | 1 | 2002 | 772 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2017 | 39228 | 0.030 |
Why?
|
Phospholipids | 1 | 2021 | 776 | 0.030 |
Why?
|
Kidney Tubules | 1 | 1999 | 453 | 0.030 |
Why?
|
Epigenomics | 1 | 2023 | 958 | 0.030 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2018 | 325 | 0.030 |
Why?
|
Mammals | 1 | 2022 | 1126 | 0.030 |
Why?
|
Pleurodesis | 1 | 2017 | 49 | 0.030 |
Why?
|
Gene Transfer Techniques | 1 | 2022 | 1206 | 0.030 |
Why?
|
Drug Synergism | 1 | 2021 | 1751 | 0.030 |
Why?
|
Melanoma-Specific Antigens | 1 | 1996 | 73 | 0.030 |
Why?
|
HCT116 Cells | 1 | 2017 | 399 | 0.030 |
Why?
|
RNA, Ribosomal | 1 | 2017 | 227 | 0.030 |
Why?
|
Adenoma, Oxyphilic | 1 | 1998 | 150 | 0.030 |
Why?
|
Rhabdomyoma | 1 | 1996 | 56 | 0.030 |
Why?
|
Treatment Failure | 1 | 2002 | 2653 | 0.030 |
Why?
|
Genetic Engineering | 1 | 2022 | 933 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 4 | 2014 | 2510 | 0.030 |
Why?
|
Sequence Deletion | 1 | 2000 | 1494 | 0.030 |
Why?
|
Education | 1 | 2018 | 531 | 0.030 |
Why?
|
Behavior | 1 | 2018 | 536 | 0.030 |
Why?
|
Green Fluorescent Proteins | 2 | 2012 | 2062 | 0.030 |
Why?
|
Neural Crest | 1 | 2017 | 277 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2000 | 1740 | 0.030 |
Why?
|
Enzyme Activation | 2 | 2014 | 3583 | 0.030 |
Why?
|
Tissue Distribution | 1 | 1999 | 2270 | 0.030 |
Why?
|
Point Mutation | 1 | 2000 | 1590 | 0.030 |
Why?
|
Promoter Regions, Genetic | 2 | 2017 | 5784 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-vav | 1 | 1995 | 91 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2018 | 702 | 0.030 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2018 | 455 | 0.030 |
Why?
|
Chromosome Breakpoints | 1 | 2014 | 93 | 0.030 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2009 | 5333 | 0.030 |
Why?
|
Metabolomics | 2 | 2014 | 1667 | 0.030 |
Why?
|
Hominidae | 1 | 1994 | 68 | 0.030 |
Why?
|
Glucose Transporter Type 2 | 1 | 2014 | 61 | 0.030 |
Why?
|
Chemokine CCL2 | 1 | 2017 | 602 | 0.030 |
Why?
|
Poland | 1 | 2014 | 197 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 2 | 2018 | 36547 | 0.030 |
Why?
|
Receptors, Estradiol | 1 | 2013 | 18 | 0.030 |
Why?
|
Glucose Transporter Type 1 | 1 | 2014 | 186 | 0.030 |
Why?
|
Carcinoma, Papillary | 1 | 1999 | 786 | 0.030 |
Why?
|
Receptors, Atrial Natriuretic Factor | 1 | 2013 | 42 | 0.030 |
Why?
|
Internationality | 1 | 2019 | 1007 | 0.030 |
Why?
|
Registries | 1 | 2010 | 8346 | 0.030 |
Why?
|
Drug Implants | 1 | 2014 | 230 | 0.030 |
Why?
|
Models, Animal | 1 | 2020 | 2120 | 0.030 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 1994 | 313 | 0.030 |
Why?
|
Activating Transcription Factors | 1 | 2013 | 30 | 0.030 |
Why?
|
Metabolic Networks and Pathways | 1 | 2018 | 797 | 0.030 |
Why?
|
Eukaryotic Initiation Factors | 1 | 2013 | 83 | 0.030 |
Why?
|
Mesoderm | 1 | 2016 | 679 | 0.030 |
Why?
|
Glutamate Dehydrogenase | 1 | 2013 | 50 | 0.030 |
Why?
|
Transplantation, Heterologous | 2 | 2013 | 2390 | 0.030 |
Why?
|
NADP | 1 | 2014 | 228 | 0.030 |
Why?
|
GTP-Binding Proteins | 1 | 1997 | 944 | 0.030 |
Why?
|
Time Factors | 3 | 2017 | 40097 | 0.030 |
Why?
|
Collagen Type IV | 1 | 2013 | 124 | 0.030 |
Why?
|
Comprehension | 1 | 2018 | 636 | 0.030 |
Why?
|
Nail-Patella Syndrome | 1 | 1992 | 12 | 0.030 |
Why?
|
DNA-Binding Proteins | 2 | 2022 | 9600 | 0.030 |
Why?
|
Valine | 1 | 2014 | 410 | 0.030 |
Why?
|
Breath Tests | 1 | 2014 | 297 | 0.030 |
Why?
|
Gene Silencing | 1 | 2019 | 1504 | 0.030 |
Why?
|
Centromere | 1 | 1993 | 213 | 0.030 |
Why?
|
Age Distribution | 1 | 1998 | 2864 | 0.030 |
Why?
|
Chromosomes, Human | 1 | 2014 | 437 | 0.030 |
Why?
|
Porphyrins | 1 | 2014 | 351 | 0.030 |
Why?
|
Contractile Proteins | 1 | 1993 | 240 | 0.020 |
Why?
|
Color Perception | 1 | 1993 | 212 | 0.020 |
Why?
|
Rabbits | 1 | 1998 | 4729 | 0.020 |
Why?
|
Drug Monitoring | 1 | 2018 | 960 | 0.020 |
Why?
|
Sequence Analysis, DNA | 2 | 2001 | 4780 | 0.020 |
Why?
|
PTEN Phosphohydrolase | 1 | 2018 | 1117 | 0.020 |
Why?
|
Airway Remodeling | 1 | 2013 | 134 | 0.020 |
Why?
|
Computer Simulation | 2 | 2016 | 6251 | 0.020 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 1993 | 348 | 0.020 |
Why?
|
Dystonia Musculorum Deformans | 1 | 1992 | 158 | 0.020 |
Why?
|
Arabidopsis Proteins | 1 | 2013 | 261 | 0.020 |
Why?
|
Chromatin | 2 | 2016 | 2979 | 0.020 |
Why?
|
Nuclear Proteins | 2 | 2018 | 5782 | 0.020 |
Why?
|
Immunocompromised Host | 1 | 2017 | 865 | 0.020 |
Why?
|
Cyclooxygenase 2 | 1 | 2014 | 594 | 0.020 |
Why?
|
Health Priorities | 1 | 2014 | 382 | 0.020 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2013 | 462 | 0.020 |
Why?
|
Lipoxins | 1 | 2014 | 419 | 0.020 |
Why?
|
ABO Blood-Group System | 1 | 1993 | 381 | 0.020 |
Why?
|
Translocation, Genetic | 2 | 1995 | 1393 | 0.020 |
Why?
|
RNA, Neoplasm | 1 | 2013 | 745 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 1 | 1992 | 1305 | 0.020 |
Why?
|
Goals | 1 | 2016 | 717 | 0.020 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 1993 | 640 | 0.020 |
Why?
|
Sequence Alignment | 1 | 1995 | 2172 | 0.020 |
Why?
|
Infant | 2 | 2006 | 36426 | 0.020 |
Why?
|
Sleep Apnea Syndromes | 1 | 2018 | 982 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2019 | 22228 | 0.020 |
Why?
|
Nanoparticles | 1 | 2022 | 1966 | 0.020 |
Why?
|
Stress, Mechanical | 1 | 2015 | 1670 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2017 | 1756 | 0.020 |
Why?
|
Farnesol | 1 | 2009 | 20 | 0.020 |
Why?
|
Organ Specificity | 1 | 1995 | 1964 | 0.020 |
Why?
|
Dystonia | 1 | 1993 | 378 | 0.020 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2021 | 1884 | 0.020 |
Why?
|
Prenylation | 1 | 2009 | 36 | 0.020 |
Why?
|
X Chromosome | 1 | 1993 | 819 | 0.020 |
Why?
|
Fluorescence | 1 | 1992 | 751 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2018 | 15878 | 0.020 |
Why?
|
Computational Biology | 1 | 2021 | 3562 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2024 | 81537 | 0.020 |
Why?
|
Diffusion of Innovation | 1 | 2014 | 723 | 0.020 |
Why?
|
Salicylates | 1 | 2009 | 125 | 0.020 |
Why?
|
Telomerase | 1 | 2014 | 749 | 0.020 |
Why?
|
Cell Membrane | 1 | 1998 | 3635 | 0.020 |
Why?
|
Disease Progression | 2 | 2019 | 13614 | 0.020 |
Why?
|
DNA, Mitochondrial | 1 | 2014 | 869 | 0.020 |
Why?
|
Retina | 1 | 1999 | 2648 | 0.020 |
Why?
|
Antigens, Neoplasm | 1 | 1996 | 1995 | 0.020 |
Why?
|
Ubiquitination | 1 | 2013 | 996 | 0.020 |
Why?
|
United States | 4 | 2018 | 72909 | 0.020 |
Why?
|
Tumor Burden | 1 | 2014 | 1888 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 613 | 0.020 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2014 | 1494 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2013 | 1331 | 0.020 |
Why?
|
China | 1 | 2014 | 2383 | 0.020 |
Why?
|
NIH 3T3 Cells | 1 | 2009 | 651 | 0.020 |
Why?
|
Golgi Apparatus | 1 | 2009 | 405 | 0.020 |
Why?
|
Disease Management | 1 | 2018 | 2530 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2011 | 1748 | 0.020 |
Why?
|
COS Cells | 1 | 2009 | 1135 | 0.020 |
Why?
|
Food Deprivation | 1 | 2007 | 115 | 0.020 |
Why?
|
Genome | 1 | 2015 | 1753 | 0.020 |
Why?
|
Cell Hypoxia | 1 | 2009 | 655 | 0.020 |
Why?
|
Pyrimidines | 1 | 2019 | 3049 | 0.020 |
Why?
|
Cell Lineage | 1 | 2016 | 2573 | 0.020 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2012 | 1143 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2002 | 11196 | 0.020 |
Why?
|
Terminology as Topic | 1 | 2014 | 1536 | 0.020 |
Why?
|
Mutagens | 1 | 2007 | 180 | 0.020 |
Why?
|
Models, Genetic | 1 | 1997 | 3447 | 0.020 |
Why?
|
Computer-Assisted Instruction | 1 | 2010 | 368 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2024 | 7423 | 0.020 |
Why?
|
Myocardium | 1 | 1999 | 4764 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2014 | 2045 | 0.020 |
Why?
|
Blotting, Southern | 2 | 1998 | 772 | 0.020 |
Why?
|
Hamartoma | 1 | 2007 | 235 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2014 | 6202 | 0.020 |
Why?
|
Protein-Tyrosine Kinases | 1 | 1994 | 2423 | 0.010 |
Why?
|
Recurrence | 1 | 2017 | 8492 | 0.010 |
Why?
|
Sex Factors | 1 | 2018 | 10611 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 1998 | 3530 | 0.010 |
Why?
|
Logistic Models | 1 | 2019 | 13273 | 0.010 |
Why?
|
Hemodynamics | 1 | 2014 | 4186 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 1999 | 4959 | 0.010 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2018 | 3247 | 0.010 |
Why?
|
Endoplasmic Reticulum | 1 | 2009 | 1132 | 0.010 |
Why?
|
Histone Deacetylases | 1 | 2007 | 714 | 0.010 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2007 | 779 | 0.010 |
Why?
|
Aspirin | 1 | 2014 | 3135 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2013 | 2894 | 0.010 |
Why?
|
Survival Rate | 1 | 2016 | 12822 | 0.010 |
Why?
|
Neurons | 1 | 2001 | 9527 | 0.010 |
Why?
|
Software | 1 | 2015 | 4462 | 0.010 |
Why?
|
Mental Disorders | 1 | 2001 | 6870 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2009 | 3733 | 0.010 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2002 | 748 | 0.010 |
Why?
|
DNA Methylation | 1 | 2014 | 4424 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2002 | 15802 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2019 | 12803 | 0.010 |
Why?
|
Endothelial Growth Factors | 1 | 2002 | 671 | 0.010 |
Why?
|
Facial Neoplasms | 1 | 2000 | 126 | 0.010 |
Why?
|
Lymphokines | 1 | 2002 | 905 | 0.010 |
Why?
|
Graft Survival | 1 | 2009 | 3904 | 0.010 |
Why?
|
Nucleic Acid Heteroduplexes | 1 | 1998 | 46 | 0.010 |
Why?
|
Incidence | 1 | 2017 | 21513 | 0.010 |
Why?
|
ral Guanine Nucleotide Exchange Factor | 1 | 1997 | 4 | 0.010 |
Why?
|
rap GTP-Binding Proteins | 1 | 1997 | 24 | 0.010 |
Why?
|
DNA Damage | 1 | 2007 | 2462 | 0.010 |
Why?
|
Models, Molecular | 1 | 2007 | 5377 | 0.010 |
Why?
|
Penetrance | 1 | 1998 | 388 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 2000 | 1885 | 0.010 |
Why?
|
Cohort Studies | 1 | 2019 | 41680 | 0.010 |
Why?
|
Ploidies | 1 | 1996 | 287 | 0.010 |
Why?
|
Pregnancy | 2 | 2013 | 30230 | 0.010 |
Why?
|
Radiation Chimera | 1 | 1995 | 216 | 0.010 |
Why?
|
DNA Fingerprinting | 1 | 1995 | 114 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-bcr | 1 | 1994 | 21 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2019 | 59496 | 0.010 |
Why?
|
Brain Chemistry | 1 | 1997 | 952 | 0.010 |
Why?
|
Family Health | 1 | 1998 | 1253 | 0.010 |
Why?
|
Genes | 1 | 1997 | 1824 | 0.010 |
Why?
|
Chromosome Banding | 1 | 1993 | 261 | 0.010 |
Why?
|
Introns | 1 | 1994 | 965 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 1997 | 4163 | 0.010 |
Why?
|
Gene Library | 1 | 1994 | 1066 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2002 | 2627 | 0.010 |
Why?
|
Cricetinae | 1 | 1995 | 2412 | 0.010 |
Why?
|
DNA Probes | 1 | 1992 | 541 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2002 | 3498 | 0.010 |
Why?
|
Polydeoxyribonucleotides | 1 | 1992 | 136 | 0.010 |
Why?
|
DNA Primers | 1 | 1994 | 2824 | 0.010 |
Why?
|
Child, Preschool | 2 | 2001 | 42510 | 0.000 |
Why?
|
Placenta | 1 | 1994 | 1726 | 0.000 |
Why?
|